CD4 and myeloid sarcoma: Our findings expand upon this as we demonstrated the presence of autoantigen-specific GM-CSF CD4+ T cells in pwMSs, suggesting that the cell population reported by Galli et al. (33) are not only MS specific but also autoreactive and hence likely pathogenic.